biontech news
Latest from biontech
Pharmaceutical firms Pfizer, BioNTech sue Poland and Hungary over Covid debts
EU member countries ordered vaccines for their population through joint purchase scheme, and so companies are bringing their case before the courts in Belgium.
Published on Dec 19, 2023 07:52 PM IST
AFP |
Moderna sues Pfizer, BioNTech for Covid vaccine patent infringement
Moderna accused Pfizer and BioNTech of violating intellectual property protecting key elements of Moderna’s messenger RNA technology in developing the Comirnaty vaccine.
Updated on Aug 26, 2022 07:18 PM IST
Bloomberg |
Qatar approves Pfizer/BioNTech vaccine for children aged 5-11 years
In November, Gulf states Bahrain and Saudi Arabia approved the Pfizer Covid-19 vaccine for emergency use for children in the same age category.
Published on Jan 30, 2022 09:21 PM IST
Reuters |
Omicron routs J&J vaccine in lab study, may evade Sinovac and BioNTech too
A study, conducted by scientists at the microbiology department of the University of Hong Kong, showed that insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.
Published on Dec 15, 2021 01:26 PM IST
Written by Joydeep Bose | Edited by Avik Roy, Hindustan Times, New Delhi
Pfizer, BioNTech say 3 doses of Covid-19 vaccine neutralise Omicron variant
Further, the companies also said that two doses of the vaccine was found less effective in protection against the Omicron variant while a booster dose increased the neutralising antibodies by 25 times.
Published on Dec 08, 2021 07:47 PM IST
Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi
Covid-19 vaccine makers study new variant’s impact
BioNTech, which works with Pfizer said it’s beginning lab studies on the variant and should have the first data on how it interacts with the vaccine within two weeks.
Updated on Nov 28, 2021 04:21 AM IST
Agencies |
What are the Covid entry rules for travellers to European countries?
As Europe begins to open up, DW offers a brief recap of what travel restrictions apply within the EU.
Updated on Aug 06, 2021 10:33 AM IST
Deutsche Welle, Delhi
Pfizer-BioNTech vaccine may require third dose, companies seek approval
The ongoing trial, conducted into the Pfizer-BioNTech Covid-19 vaccine, has shown that a third dose can push antibody levels five to 10 times higher against the said variants of the coronavirus compared to the first two doses alone.
Published on Jul 09, 2021 06:19 AM IST
hindustantimes.com | Written by Joydeep Bose | Edited by Avik Roy
Know all about whether your child should get the Covid-19 vaccine or not
As emergency use authorisation of the Pfizer-BioNTech Covid-19 vaccine extends to include adolescents between 12 to 15 years of age, here are answers to certain queries parents may have about their teen or preteen getting the Covid-19 vaccine.
Updated on May 17, 2021 05:06 PM IST
PTI |
Germany plans to ease Covid-19 quarantine for fully-vaccinated travellers
Germany to ease Covid-19 quarantine for travellers who have had a coronavirus vaccine approved in the European Union, namely BioNTech/Pfizer, Moderna, AstraZeneca and Johnson & Johnson.
_1616400870202_1620812099750.jpg "Germany plans to ease Covid-19 quarantine for fully-vaccinated travellers(Photo by Sangga Rima Roman Selia on Unsplash)")
Updated on May 12, 2021 03:07 PM IST
Reuters |
BioNTech aims to manufacture 2.5 billion Covid-19 vaccine doses this year
Pfizer and BioNTech had previously spoken of being able to make 2 billion doses in 2021.
Updated on Mar 30, 2021 05:47 PM IST
AP |
No progress in BioNTech vaccine talks, says Taiwan
Taiwan complained last month that the firm had pulled out of a deal to sell it 5 million doses at the last minute, possibly due to Chinese pressure. BioNTech responded by saying it did plan on providing the vaccine.
Published on Mar 29, 2021 12:22 PM IST
Reuters | , Taipei
Vaccine production needs to get even faster, says BioNTech CEO
A year after Covid-19 was declared a pandemic, the world would be well advised to prepare for the next one.
Published on Mar 13, 2021 12:45 PM IST
Bloomberg |
Israel trades medical data with Pfizer to maintain supply of Covid-19 vaccines
Proponents say the deal could allow Israel to become the first country to vaccinate most of its population, while providing valuable research that could help the rest of the world.
Published on Jan 18, 2021 12:32 PM IST
PTI | , Jerusalem
UK set to begin ‘marathon’ Covid-19 vaccination drive
Health secretary Matt Hancock called it a “historic moment”, while Stephen Powis, England’s medical director, noted logistical challenges involved and cautioned that Tuesday would mark the beginning of a long haul, calling the vaccination programme “a marathon, not a sprint”.
Updated on Dec 07, 2020 07:16 PM IST
Hindustan Times, London | Prasun Sonwalkar , edited by Vinod Janardhanan
UK regulator begins assessing Pfizer-BioNTech vaccine data
Since the UK continues to be a member of the EU until the end of the Brexit transition period on December 31, Covid-19 vaccine candidates can be licensed via the Amsterdam-based European Medicines Agency and that authorisation will automatically be valid in the UK.
Updated on Nov 23, 2020 07:10 PM IST
Hindustan Times, London | Prasun Sonwalkar , edited by Vinod Janardhanan